Lv, KeKeLvZhai, HongyanHongyanZhaiJiang, YuxinYuxinJiangLiang, PingPingLiangXu, Hui-XiongHui-XiongXuDu, LianfangLianfangDuChou, Yi-HongYi-HongChouXie, XiaoyanXiaoyanXieLuo, YuKunYuKunLuoLee, Young JoonYoung JoonLeeLee, Jae YoungJae YoungLeeHu, BingBingHuLuo, BaomingBaomingLuoWang, YiYiWangLuan, YingYingLuanKalli, ChristinaChristinaKalliChen, KunKunChenWang, WenpingWenpingWangJA-DER LIANG2022-02-162022-02-162021-102366-004Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/594639To assess the respective diagnostic value of Sonazoid™ and SonoVue® for characterizing FLLs as benign or malignant and the corresponding safety.enCharacterization; Contrast-enhanced ultrasound; Diagnostic accuracy; Focal liver lesions; Vascular imaging[SDGs]SDG3[SDGs]SDG4Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesionsjournal article10.1007/s00261-021-03010-1341369362-s2.0-85108154145WOS:000662138800002https://api.elsevier.com/content/abstract/scopus_id/85108154145